Close Menu
  • Home
  • International
  • News
  • Lifestyle
  • Law
  • Business
  • Education
  • Vaping

Subscribe to Updates

Get the latest creative news from FooBar about art, design and business.

What's Hot

Client Challenge

June 5, 2026

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026

Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

June 5, 2026
Facebook X (Twitter) Instagram
Friday, June 5
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions
Facebook X (Twitter) Instagram LinkedIn VKontakte
Smoke Advantage
  • Home
  • International

    Medical Cannabis Patients Report Reduced Prescription Drug Use

    May 8, 2026

    Cannabis Europa Heads to London Amid €1.5 Billion European Market Surge

    May 6, 2026

    Ananda Pharma to Begin Dosing in NHS CBD Endometriosis Trial

    March 7, 2026
  • News

    Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

    June 5, 2026

    Exercise common amongst cannabis users, new study finds

    June 5, 2026

    Amsterdam Drops Coffeeshop Tourist Ban In New Coalition Deal

    June 4, 2026

    Wyoming Official Issues ‘Objection’ To Rescheduling Marijuana Under State Law Following Trump’s Federal Move

    June 4, 2026

    UK Medical Cannabis Patients Report Improved Mental Health Symptoms

    June 3, 2026
  • Lifestyle

    Rappin’ The Rivers Is Building Montana’s Hip-Hop Outpost

    June 4, 2026

    Harry Styles Says He Did A Lot of Mushrooms Making ‘Fine Line.’ A Top Psychedelic Scientist Explains Why It Tracks.

    May 31, 2026

    Twenty-One Years Later, Conor Oberst Is More Wide Awake Than Ever

    May 29, 2026

    What the VA Won’t Prescribe: A Joint

    May 27, 2026

    Scary Movie Went All In On Marketing To Stoners. A Vape, A Bong Popcorn Bucket, The Whole Thing.

    May 25, 2026
  • Law

    Client Challenge

    June 5, 2026

    Kentucky Gov. Signs Order to Add 15 New Qualifying Conditions for Medical Cannabis

    June 4, 2026

    Minnesota Gov. Signs Law Streamlining Medical and Adult-Use Cannabis Supply Chains

    June 2, 2026

    NORML Seeks to Participate in DEA Hearings on Cannabis Rescheduling 

    May 29, 2026

    Massachusetts Regulators to Audit Cannabis THC Potency Levels

    May 26, 2026
  • Business

    They Already Ruined Cannabis. Now Psychedelics Are Next.

    June 5, 2026

    The Cannabis Consumer Has Grown Up. Has Your Hardware?  – Cannabis & Tech Today

    June 4, 2026

    Pre-Rolls Overtake Flower as Consumer Preferences Shift – Cannabis & Tech Today

    May 30, 2026

    Marc Shepard Built NECANN for the Locals

    May 29, 2026

    Federal Labor Decision Inspires More Missouri Marijuana Workers To Seek Unionization

    May 27, 2026
  • Education

    The “Canna-Tourism” Guide to the Twin Cities

    June 4, 2026

    CBD Dosage Guide for Beginners (India) – Buy CBD Oil India | Licensed Under Ministry of Ayush

    June 2, 2026

    Marijuana Components Have ‘Consistent’ Anti-Tumor Effects In Glioblastoma And Other Cancers, Scientific Review Shows

    May 31, 2026

    Beyond Cannabinoids: Unlocking Cannabistilbenes

    May 29, 2026

    How the Endocannabinoid System Controls Sleep, Mood & Pain – Buy CBD Oil India | Licensed Under Ministry of Ayush

    May 27, 2026
  • Vaping

    France’s Criminilization of Nicotine Pouches Raises Questions Over Tobacco Harm Reduction Policy

    June 4, 2026

    Psychedelics, Vapes and Smart Apps: Smoking Cessation Science Evolves Beyond Traditional NRTs

    June 2, 2026

    Review: Coolfire Z Air – Innokin

    May 31, 2026

    Tobacco Harm Reduction: An Especially Beneficial Public Health Tool for Disadvantaged Groups

    May 29, 2026

    Global Vaping Research 2026: Cancer Concerns, Nicotine Science and Smoking Cessation Evidence

    May 27, 2026
Smoke Advantage
You are at:Home»Business»Darren Gleeman on Tax Strategy, Exits, and Employee Ownership  – Cannabis & Tech Today
Business

Darren Gleeman on Tax Strategy, Exits, and Employee Ownership  – Cannabis & Tech Today

adminBy adminApril 2, 2026No Comments6 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
Darren Gleeman on Tax Strategy, Exits, and Employee Ownership  – Cannabis & Tech Today
Share
Facebook Twitter LinkedIn Pinterest Email

The cannabis industry has no shortage of financial hurdles, but few innovators are rewriting the financial playbook to meet operators where they are. With a background in hedge funds and high-frequency trading, Darren Gleeman didn’t arrive in cannabis to ride a trend. He arrived to fix a broken system. In a space where traditional M&A is limited and Section 280E guts profitability, Gleeman and his team at MBO Ventures have introduced an alternative: a patent pending ESOP model that makes federal income tax, and the pain of 280E, virtually disappear.

As the cannabis industry’s only ESOP-focused investment bank, MBO Ventures has helped execute the industry’s first ESOP exit, preserving founder equity, boosting employee ownership, and turning tax liabilities into long-term value.

In this interview, Gleeman shares how he’s using financial engineering to solve one of the industry’s most entrenched challenges and why he believes ESOPs might be the future of not just cannabis exits, but equitable capitalism.

Cannabis & Tech Today: You’ve called 280E “the silent killer” of cannabis businesses. For readers less familiar with the tax code, can you explain how it impacts cash flow and valuations, and why it creates such a challenge for exits?

Darren Gleeman: 280E disallows cannabis companies from deducting ordinary business expenses. That means even if a company breaks even or loses money on a pre-tax basis, it still pays full federal income tax on gross profit. This crushes cash flow, which in turn suppresses growth and hence valuation multiples are almost non-existent. Buyers don’t want to acquire companies that have very little cash flow due to income tax, and sellers can’t justify their prices based on after-tax earnings. The result is a market with stalled M&A activity and owners with no viable exit path.

C&T Today: Traditional M&A hasn’t taken off in cannabis the way many expected. What’s missing from the current exit landscape that the ESOP model helps solve?

DG: Buyers either don’t exist or are offering fire-sale prices. Most of the large MSOs are capital constrained, and traditional PE avoids cannabis due to federal illegality. Our ESOP model flips the buyer-seller dynamic: the company sells to a trust for the benefit of the employees, using seller financing and future profits to fund the transaction. The owner gets liquidity and upside through warrants, while the company pays zero federal income tax, making the deal financially viable where others fail.

Darren Gleeman is the Managing Partner of MBO Ventures, a firm that specializes in business exits through tax-advantaged ESOP structures.

C&T Today: What inspired you to adapt ESOPs, typically used in more mature industries, for cannabis operators? What did you see that others missed? No one else was solving the 280E problem.

DG: Everyone kept asking how to find buyers. I asked how to make the company more profitable without a buyer. The answer was eliminating taxes. When you remove federal and state income tax, cash flow doubles or triples, and that’s without cutting costs or adding revenue. ESOPs already existed. I just applied them to a space where tax inefficiency is the core issue.

C&T Today: Your ESOP methodology has a patent pending. At a high level, what makes your approach different from a standard ESOP structure?

DG: It’s about structural edge. Just like in my previous hedge fund, the advantage doesn’t come from doing something others can’t… it comes from doing it differently. Our model isn’t built around tweaks or legal gimmicks. It’s a fundamentally different way of thinking about ownership, taxation, and alignment. The edge is in the structure.

C&T Today: You’ve executed every ESOP in the cannabis cannabis to-date. What surprised you most during those early transactions, either from the business owners or the employees?

DG: Business owners were skeptical at first. They thought ESOPs were complicated or too good to be true. Once they saw the math—no taxes, full deduction of the purchase price, deferred capital gains—it became real. Employees, on the other hand, didn’t always grasp it immediately. But when they understood they owned the company and that it paid no taxes, it changed the conversation.

C&T Today: Many cannabis founders worry about “losing control” or diluting their vision. How does the ESOP model preserve culture while still enabling an exit?

DG: Founders still manage the company (assuming they still want to)  The ESOP trust is a passive shareholder. The board of directors governs the company. If the founder wants to stay, and the Board wants them, they can stay to operate the company. If they want to leave, the Board can install a new CEO. Culture isn’t lost because the people running the company—management—don’t change unless the founder wants them to.

C&T Today: We hear a lot about creating generational wealth in cannabis. How does employee ownership factor into that conversation, and how do employees typically respond?

DG: In traditional exits, employees get nothing. With an ESOP, they’re the buyer via this employee trust. The longer the employees stay, the more they accumulate. It’s not a lottery ticket. It’s wealth earned through continued work. For many, it’s the first time they’ve had any ownership in a company. Over time, this builds retirement value that wouldn’t exist under traditional structures.

C&T Today: As someone who comes from the world of hedge funds and high-frequency trading, what perspectives or skills have you brought into this highly regulated, people-driven space?

DG: I bring quantitative thinking to a market that often lacks financial structure. Hedge funds are built on tax arbitrage and capital efficiency. Cannabis is the opposite—tax-inefficient and capital-starved. So I apply the same logic from trading: eliminate friction, optimize after-tax returns, and find structural edges others overlook. That’s what the ESOP does.

C&T Today: With federal rescheduling on the table, how might that shift the value proposition of ESOPs in the cannabis sector?

DG: If 280E disappears, then all companies get a boost in cash flow. This is awesome. The difference is, an ESOP still pays zero federal income tax and zero state income tax. That advantage doesn’t go away. If anything, it increases valuations across the board, making ESOP exits even more attractive for owners looking to defer capital gains and retain upside.

C&T Today: Finally, for cannabis business owners who feel stuck, burned out but hesitant to sell, what’s the one question you think they should be asking themselves right now?

Ask yourself: “Why am I still paying income tax and worrying about 280E when there’s a structure that can eliminate income tax entirely and double my cash flow?” Most owners think their only options are to grind it out or sell at a discount. But there’s a third path, an ESOP, that lets the business pay zero income tax, giving you the freedom to stay, step back, or exit gradually, all while keeping the future upside.

  • Cannabis & Tech Today is the premier publication for inspiring business profiles, exclusive interviews with thought leaders in the field, science innovations, and insights on new legislation and growth in the cannabis market.

Source link

cannabis Darren Employee Exits Gleeman Ownership Strategy Tax tech Today
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email
Previous ArticleOliver’s Law Campaign Could Reshape Medical Cannabis Prescribing
Next Article DC Mayor Proposes To Let Medical Marijuana And Alcohol Companies Partner On THC Drinks
admin

Related Posts

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026

Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

June 5, 2026

Exercise common amongst cannabis users, new study finds

June 5, 2026

Comments are closed.

Our Picks

Client Challenge

June 5, 2026

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026

Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

June 5, 2026

Exercise common amongst cannabis users, new study finds

June 5, 2026
  • Facebook
  • Twitter
  • Pinterest
  • Instagram
  • YouTube
  • Vimeo
Don't Miss
Law

Client Challenge

By adminJune 5, 20260

Client Challenge JavaScript is disabled in your browser. Please enable JavaScript to proceed. A required…

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026

Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

June 5, 2026

Exercise common amongst cannabis users, new study finds

June 5, 2026

Subscribe to Updates

Get the latest creative news from Smoke Unlimited about Weed & CBD vaping.

From Our Partners
About Us
About Us

Get all the current news stories, latest trends and legislation regarding cannabidiol, products, usages and its benefits. So don’t miss out any buzz and stay tuned! We offer a minute to minute updates regarding Marijuana industry.

Facebook X (Twitter) Instagram Pinterest
Our Picks

Client Challenge

June 5, 2026

They Already Ruined Cannabis. Now Psychedelics Are Next.

June 5, 2026

Vertanical Secures FDA Breakthrough Designation for Cannabis Pain Drug

June 5, 2026
Sponsors
Copyright © 2026. SmokeAdvantage.com
  • Home
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.